XML 38 R24.htm IDEA: XBRL DOCUMENT
v3.20.2

SEGMENT INFORMATION | 9 Months Ended
--- | ---
Sep. 30, 2020
Segment Reporting [Abstract] |
SEGMENT INFORMATION | SEGMENT INFORMATION We are organized into three reporting segments. Our Beauty + Home segment sells to the personal care, beauty and home care markets. Our Pharma segment serves customers in the prescription drug, consumer health care, injectables and active packaging markets. Our Food + Beverage segment sells to the food and beverage markets. The accounting policies of the segments are the same as those described in Part II, Item 8, Note 1 - Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2019. We evaluate performance of our business units and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring initiatives and acquisition-related costs. All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are based on segment Adjusted EBITDA. Financial information regarding our reporting segments is shown below:
​ | Three Months Ended September 30, 2020 |  | Nine Months Ended September 30, 2020
​ | 2020 |  | 2019 |  | 2020 |  | 2019
Total Sales: | ​ |  | ​ |  | ​ |  | ​
Beauty + Home | $ | 342,710 |  |  | $ | 333,870 |  |  | $ | 979,645 |  |  | $ | 1,056,626 |
Pharma | 317,610 |  |  | 271,608 |  |  | 921,085 |  |  | 830,679 |
Food + Beverage | 106,667 |  |  | 104,458 |  |  | 305,991 |  |  | 328,280 |
Total Sales | 766,987 |  |  | 709,936 |  |  | $ | 2,206,721 |  |  | $ | 2,215,585 |
Less: Intersegment Sales: | ​ |  | ​ |  | ​ |  | ​
Beauty + Home | $ | 5,479 |  |  | $ | 5,688 |  |  | $ | 18,068 |  |  | $ | 18,705 |
Pharma | 1,852 |  |  | 2,357 |  |  | 6,872 |  |  | 6,788 |
Food + Beverage | 503 |  |  | 613 |  |  | 1,770 |  |  | 1,693 |
Total Intersegment Sales | $ | 7,834 |  |  | $ | 8,658 |  |  | $ | 26,710 |  |  | $ | 27,186 |
Net Sales: | ​ |  | ​ |  | ​ |  | ​
Beauty + Home | $ | 337,231 |  |  | $ | 328,182 |  |  | $ | 961,577 |  |  | $ | 1,037,921 |
Pharma | 315,758 |  |  | 269,251 |  |  | 914,213 |  |  | 823,891 |
Food + Beverage | 106,164 |  |  | 103,845 |  |  | 304,221 |  |  | 326,587 |
Net Sales | $ | 759,153 |  |  | $ | 701,278 |  |  | $ | 2,180,011 |  |  | $ | 2,188,399 |
Adjusted EBITDA (1): | ​ |  | ​ |  | ​ |  | ​
Beauty + Home | $ | 34,733 |  |  | $ | 41,475 |  |  | $ | 92,954 |  |  | $ | 143,411 |
Pharma | 112,436 |  |  | 95,899 |  |  | 324,877 |  |  | 294,684 |
Food + Beverage | 20,351 |  |  | 18,728 |  |  | 53,543 |  |  | 56,363 |
Corporate & Other, unallocated | (10,964) |  |  | (9,943) |  |  | (34,071) |  |  | (33,328) |
Acquisition-related costs (2) | (221) |  |  | (708) |  |  | (6,087) |  |  | (1,767) |
Restructuring Initiatives (3) | (3,415) |  |  | (6,019) |  |  | (15,585) |  |  | (17,286) |
Depreciation and amortization | (55,179) |  |  | (49,218) |  |  | (162,414) |  |  | (144,574) |
Interest Expense | (8,851) |  |  | (8,898) |  |  | (25,973) |  |  | (26,868) |
Interest Income | 249 |  |  | 957 |  |  | 599 |  |  | 3,738 |
Income before Income Taxes | $ | 89,139 |  |  | $ | 82,273 |  |  | $ | 227,843 |  |  | $ | 274,373 |
________________________________________________ (1)We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring initiatives and acquisition-related costs. (2)Acquisition-related costs include transaction costs and purchase accounting adjustments related to acquisitions and investments (see Note 17 – Acquisitions and Note 18 – Investment in Equity Securities for further details). (3)Restructuring Initiatives includes expense items for the three and nine months ended September 30, 2020 and 2019 as follows (see Note 19 – Restructuring Initiatives for further details): ​
​ | Three Months Ended September 30, 2020 |  | Nine Months Ended September 30, 2020
​ | 2020 |  | 2019 |  | 2020 |  | 2019
Restructuring Initiatives by Segment | ​ |  | ​ |  | ​ |  | ​
Beauty + Home | $ | 3,144 |  |  | $ | 5,341 |  |  | $ | 15,375 |  |  | $ | 14,869 |
Pharma | 300 |  |  | 168 |  |  | 158 |  |  | 381 |
Food + Beverage | (31) |  |  | 204 |  |  | 147 |  |  | 826 |
Corporate & Other | 2 |  |  | 306 |  |  | (95) |  |  | 1,210 |
Total Restructuring Initiatives | $ | 3,415 |  |  | $ | 6,019 |  |  | $ | 15,585 |  |  | $ | 17,286 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration